When dyspnea worsens in pulmonary arterial hypertension: is it only disease progression?

29 August 2026 (17:44 - 18:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Aybuke Geylan

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

4 More presentations in this session

Presentation thumbnail

Pulmonary hypertension in the real world - get ready for the session

Doctor N. Sari (Jakarta, ID)

Presentation thumbnail

Uncovering the hidden face of new-onset dyspnoea in a young woman with systemic sclerosis

Doctor S. Badoiu (Bucharest, RO)

Presentation thumbnail

Vanishing thrombus, persisting pressure: CTEPH as the final destination in a complex case of systemic lupus erythematosus

Doctor H. Gamal (Cairo, EG)

Presentation thumbnail

Sotatercept as an alternative therapeutic strategy in high-risk pulmonary hypertension associated with systemic sclerosis and interstitial lung disease when prostacyclin therapy is not feasible

Doctor M. Colugnat (Cdad. Autonoma de Buenos Aires, AR) Mrs E. Gutierrez Ortiz (Madrid, ES)

Access the full session

Session thumbnail

Pulmonary hypertension in the real world

The Event

Event poster

ESC Congress 2026

29 August 2026 17:44 CET

You may be interested in

Congress Session

Pulmonary hypertension complexities in investigation and management

30 August 2025

Congress Presentation

Young lady's struggle with pulmonary hypertension

28 August 2023

Congress Presentation

Left main artery compression in the setting of pulmonary artery dilation

17 May 2025

Congress Presentation

Complications of an already complicated condition: a challenging case of pulmonary hypertension.

18 March 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources